Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
出版年份 2011 全文链接
标题
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
作者
关键词
-
出版物
ALLERGY
Volume 67, Issue 2, Pages 147-157
出版商
Wiley
发表日期
2011-12-02
DOI
10.1111/j.1398-9995.2011.02751.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Results From FAST-3: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Subcutaneous Icatibant in Patients with Acute Hereditary Angioedema (HAE) Attacks
- (2011) W.R. Lumry et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients
- (2010) A. Zanichelli et al. ALLERGY
- The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007
- (2010) Marya D. Zilberberg et al. ALLERGY AND ASTHMA PROCEEDINGS
- FDA approves kallikrein inhibitor to treat hereditary angioedema
- (2010) C. A. Thompson AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients
- (2010) Konrad Bork et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Response time for ecallantide treatment of acute hereditary angioedema attacks
- (2010) Marc Riedl et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema
- (2010) Robyn J. Levy et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks
- (2010) Richard L. Wasserman et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Long-term efficacy of danazol treatment in hereditary angioedema
- (2010) George Füst et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey
- (2010) Ibolya Czaller et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week
- (2010) Konrad Bork et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Hypersensitivity Reactions Following Ecallantide Treatment for Acute Attacks of HAE
- (2010) P.T. Horn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema
- (2010) Bruce Zuraw et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema
- (2010) Lilian Varga et al. MOLECULAR IMMUNOLOGY
- Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema
- (2010) Marco Cicardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema
- (2010) Bruce L. Zuraw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
- (2010) Marco Cicardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of evidence-based medicine and clinical trials in rare genetic disorders
- (2009) MC Kruer et al. CLINICAL GENETICS
- Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: Two clinical trials in healthy volunteers and patients with hereditary angioedema
- (2009) Rakesh S. Birjmohun et al. CLINICAL THERAPEUTICS
- The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study
- (2009) Henriette Farkas et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks
- (2009) Timothy J. Craig et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis
- (2009) Wolfhart Kreuz et al. TRANSFUSION
- Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study
- (2009) Inmaculada Martinez-Saguer et al. TRANSFUSION
- Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema
- (2008) K. Bork et al. ALLERGY
- Appraisal of danazol prophylaxis for hereditary angioedema
- (2008) Timothy J. Craig ALLERGY AND ASTHMA PROCEEDINGS
- Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
- (2008) Andreas Lehmann EXPERT OPINION ON BIOLOGICAL THERAPY
- Therapeutic potential of icatibant (HOE-140, JE-049)
- (2008) Nicholas LM Cruden et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hereditary Angioedema
- (2008) Bruce L. Zuraw NEW ENGLAND JOURNAL OF MEDICINE
- Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients
- (2007) Róbert Szegedi et al. ATHEROSCLEROSIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started